Have a personal or library account? Click to login
Some aspects of the diagnosis and treatment of eosinophilic granuloma in cats Cover

Some aspects of the diagnosis and treatment of eosinophilic granuloma in cats

Open Access
|Dec 2023

Abstract

Introduction

Eosinophils represent the most active cells in mammals that show protective and assistive activity in the host immune defence against helminth parasites. These cells are also responsible for the reduction of allergic and inflammatory reactions. The eosinophils play a key role in allergic reactions by secretion of different chemical molecules leading to swelling, lesions and granuloma onset.

Material and Methods

The study was carried out on 30 cats with inflammatory skin lesions. The cats ranged in age from seven months to 13 years, and had an average age of three years. The research methodology included information on the disease, dermatological conclusions, concomitant disorders, medical and laboratory data and the treatment strategy.

Results

In total, 30 cats were diagnosed with eosinophilic granuloma complex. The distribution of lesions was 87.1% in the skin and 12.9% at the skin–mucosal junction. The lesions increased and decreased with the seasons of spring and summer, and the onset of the disease usually coincided with exposure to fleas.

Conclusion

Eosinophilic granuloma complex in cats is a serious pathology and frequently requires lifelong treatment, so it is important to diagnose it quickly and accurately to ensure optimal treatment of affected animals.

Language: English
Page range: 619 - 626
Submitted on: May 18, 2023
|
Accepted on: Oct 13, 2023
|
Published on: Dec 19, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Hanna Omelchenko, Natalia Avramenko, Serhii Kulynych, Maksym Petrenko, Vladyslav Volosovets, Natalia Volosovets, Grzegorz Woźniakowski, published by National Veterinary Research Institute in Pulawy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.